Investment Thesis
Newton Biocapital focuses on investing in life sciences projects that address chronic health conditions, leveraging its team’s scientific and medical expertise to support portfolio companies through board participation and strategic guidance in preclinical and clinical program selection.
Stage Focus
Mature innovation and growth-stage companies
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Promising solutions in chronic health conditions, preclinical and clinical programs, medical technologies, and disease areas
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€60,275,000 - €77,775,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...